Log in
Enquire now
‌

Acquisition of Agilis Biotherapeutics by PTC Therapeutics

PTC Therapeutics was acquired by PTC Therapeutics for $200 million.

OverviewStructured DataIssuesContributors

PTC Therapeutics announced its plans to acquire Agilis Biotherapeutics on July 19, 2019. The deal closed on August 23, 2018, with an upfront payment of $50 million in cash and $150 million in stock holdings bringing the total purchase price to $200 million.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like Acquisition of Agilis Biotherapeutics by PTC Therapeutics

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo